Filing Flows › AtriCure (ATRC) › Capital expenditures
AtriCure (ATRC) capital expenditures by quarter
AtriCure's capital expenditures were $6.4M in Q3 2026 (third quarter 2026), +70% from Q2 2026. Over the last 5 quarters it ranged from $1.6M (Q4 2025) to $6.4M (Q3 2026).
| Quarter | Capital expenditures | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $6.4M | +70% | +145% |
| Q2 2026 | $3.8M | +135% | +41% |
| Q4 2025 | $1.6M | -39% | — |
| Q3 2025 | $2.6M | -2% | — |
| Q2 2025 | $2.7M | — | — |
Q3 2026 at a glance
AtriCure, Q3 2026: revenue $154M (+15% year over year), operating margin 2.8%, net earnings $4.1M, operating cash flow $30.3M. The chart follows the revenue to costs, profit and cash.
Questions
What is AtriCure's capital expenditures?
AtriCure's capital expenditures were $6.4M in Q3 2026 (third quarter 2026), +70% from Q2 2026.
How has AtriCure's capital expenditures changed?
Over the last 5 quarters it ranged from $1.6M (Q4 2025) to $6.4M (Q3 2026).